ACE2 and infection: While it is now generally accepted that patients should not discontinue prescribed RAS inhibitors [reviewed in references (2, 46)], there have been conflicting reports of the influence of these drugs on ACE2 expression (46, –, 49) and whether this is sufficient to alter host cell entry or increase tissue infection.